Correlation Between Revolution Medicines and Affimed NV
Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and Affimed NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and Affimed NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revolution Medicines and Affimed NV, you can compare the effects of market volatilities on Revolution Medicines and Affimed NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of Affimed NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and Affimed NV.
Diversification Opportunities for Revolution Medicines and Affimed NV
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Revolution and Affimed is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and Affimed NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Affimed NV and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with Affimed NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Affimed NV has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and Affimed NV go up and down completely randomly.
Pair Corralation between Revolution Medicines and Affimed NV
Given the investment horizon of 90 days Revolution Medicines is expected to generate 0.7 times more return on investment than Affimed NV. However, Revolution Medicines is 1.43 times less risky than Affimed NV. It trades about -0.08 of its potential returns per unit of risk. Affimed NV is currently generating about -0.19 per unit of risk. If you would invest 4,317 in Revolution Medicines on December 30, 2024 and sell it today you would lose (582.00) from holding Revolution Medicines or give up 13.48% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Revolution Medicines vs. Affimed NV
Performance |
Timeline |
Revolution Medicines |
Affimed NV |
Revolution Medicines and Affimed NV Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Revolution Medicines and Affimed NV
The main advantage of trading using opposite Revolution Medicines and Affimed NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, Affimed NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Affimed NV will offset losses from the drop in Affimed NV's long position.Revolution Medicines vs. Blueprint Medicines Corp | Revolution Medicines vs. Sana Biotechnology | Revolution Medicines vs. Kymera Therapeutics | Revolution Medicines vs. Monte Rosa Therapeutics |
Affimed NV vs. ADC Therapeutics SA | Affimed NV vs. Agenus Inc | Affimed NV vs. X4 Pharmaceuticals | Affimed NV vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |